{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:49:33Z","timestamp":1787701773070,"version":"build-2784847793"},"reference-count":25,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Mycoplasma genitalium (M. genitalium) poses a significant public health challenge due to its association with non-gonococcal urethritis (particularly in men) and antimicrobial resistance. However, despite the prevalence of M. genitalium infections and the rise in resistance rates, routine testing and surveillance remain limited. This is the first study from Croatia that aimed to assess the prevalence and trends of resistance in M. genitalium strains isolated from male individuals by detecting macrolide and fluoroquinolone resistance genes. The study also aimed to explore the factors associated with resistance and changes in resistance patterns over time. Urine samples collected from male individuals in the Zagreb County and northwest region of Croatia between 2018 and 2023 were tested for M. genitalium with the use of molecular methods. Positive samples were subjected to DNA extraction and multiplex tandem polymerase chain reaction (MT-PCR) targeting genetic mutations associated with macrolide (23S rRNA gene) and fluoroquinolone (parC gene) resistance. Of the 8073 urine samples tested from 6480 male individuals (and following the exclusion of repeated specimens), we found that the prevalence of M. genitalium infection was 2.2%. Macrolide resistance was observed in 60.4% of strains, while fluoroquinolone resistance was found in 19.2%. Co-resistance to both antibiotics was present in 18.2% of cases. A statistically significant increase in fluoroquinolone resistance was noted over the study period (p = 0.010), but this was not evident for azithromycin resistance (p = 0.165). There were no statistically significant differences in resistance patterns between age groups, whereas re-testing of patients revealed dynamic changes in resistance profiles over time. The high burden of macrolide resistance and increasing fluoroquinolone resistance underscore the urgent need for comprehensive resistance testing and surveillance programs. The implementation of resistance-guided treatment strategies, along with enhanced access to molecular diagnostics, is pivotal for effectively managing M. genitalium infections.<\/jats:p>","DOI":"10.3390\/genes15040470","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T10:11:55Z","timestamp":1712571115000},"page":"470","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Detection of Macrolide and\/or Fluoroquinolone Resistance Genes in Mycoplasma genitalium Strains Isolated from Men in the Northwest Region of Croatia in 2018\u20132023"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6405-6922","authenticated-orcid":false,"given":"Sun\u010danica","family":"Ljubin-Sternak","sequence":"first","affiliation":[{"name":"Clinical Microbiology Department, Teaching Institute of Public Health \u201cDr Andrija \u0160tampar\u201d, 10000 Zagreb, Croatia"},{"name":"Medical Microbiology Department, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8751-8149","authenticated-orcid":false,"given":"Tomislav","family":"Me\u0161trovi\u0107","sequence":"additional","affiliation":[{"name":"University Centre Vara\u017edin, University North, 42000 Vara\u017edin, Croatia"},{"name":"Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Marijan","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Department, Teaching Institute of Public Health \u201cDr Andrija \u0160tampar\u201d, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Anu\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Department, Teaching Institute of Public Health \u201cDr Andrija \u0160tampar\u201d, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"\u0160uto","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Department, Teaching Institute of Public Health \u201cDr Andrija \u0160tampar\u201d, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Vrane\u0161","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Department, Teaching Institute of Public Health \u201cDr Andrija \u0160tampar\u201d, 10000 Zagreb, Croatia"},{"name":"Medical Microbiology Department, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jdv.17972","article-title":"2021 European Guideline on the Management of Mycoplasma genitalium Infections","volume":"36","author":"Jensen","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Waites, K.B., Crabb, D.M., Ratliff, A.E., Geisler, W.M., Atkinson, T.P., and Xiao, L. (2023). Latest Advances in Laboratory Detection of Mycoplasma genitalium. J. Clin. Microbiol., 61.","DOI":"10.1128\/jcm.00790-21"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.lanepe.2023.100737","article-title":"Treatment of bacterial sexually transmitted infections in Europe: Gonorrhoea, Mycoplasma genitalium, and syphilis","volume":"34","author":"Giacani","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/0956462421999287","article-title":"High prevalence and resistance rates of Mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in the Netherlands","volume":"32","author":"Hetem","year":"2021","journal-title":"Int. J. STD AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bradshaw, C.S., Chen, M.Y., and Fairley, C.K. (2008). Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003618"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2010.05.011","article-title":"Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance","volume":"36","author":"Shimada","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_7","first-page":"553","article-title":"Doxycycline in the management of sexually transmitted infections","volume":"73","author":"Peyriere","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.12963","article-title":"Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR","volume":"29","author":"Wold","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: A systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","first-page":"1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/cid\/ciz1031","article-title":"Resistance-Guided Antimicrobial Therapy Using Doxycycline\u2013Moxifloxacin and Doxycycline\u20132.5 g Azithromycin for the Treatment of Mycoplasma genitalium Infection: Efficacy and Tolerability","volume":"71","author":"Durukan","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e066368","DOI":"10.1136\/bmjopen-2022-066368","article-title":"Prevalence of fluoroquinolone resistance-associated mutations in Mycoplasma genitalium among clients of two sexual health centres in the Netherlands: A Cross-Sectional Study","volume":"12","author":"Braam","year":"2022","journal-title":"BMJ Open"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/OLQ.0000000000001493","article-title":"Frequency and Correlates of Mycoplasma genitalium Antimicrobial Resistance Mutations and Their Association With Treatment Outcomes: Findings From a National Sentinel Surveillance Pilot in England","volume":"48","author":"Fifer","year":"2021","journal-title":"Sex. Transm. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eimc.2021.02.004","article-title":"Mycoplasma genitalium: Analysis of mutations associated with macrolide resistance in Lleida, Spain","volume":"40","author":"Santa","year":"2022","journal-title":"Enfermedades Infecc. Y Microbiol. Clin. Engl. Ed."},{"key":"ref_15","first-page":"254","article-title":"Prevalence of macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in metropolitan and overseas France","volume":"99","author":"Pereyre","year":"2023","journal-title":"Sex. Transm. Infect."},{"key":"ref_16","first-page":"2300318","article-title":"Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022","volume":"29","author":"Smet","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_17","first-page":"248","article-title":"Mycoplasma genitalium: Enhanced management using expanded resistance-guided treatment strategies","volume":"19","author":"Sweeney","year":"2022","journal-title":"Sex. Health"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/infdis\/jis356","article-title":"Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: Predictors and persistence after therapy","volume":"206","author":"Lensing","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Edelstein, I.A., Guschin, A., Romanov, A.V., Negasheva, E.S., and Kozlov, R. (2023). Genetic Determinants of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium and Their Prevalence in Moscow, Russia. Pathogens, 12.","DOI":"10.3390\/pathogens12030496"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chiribau, C.B., Schmedes, S.E., Dong, Y., Tarigopula, N., Tekin, O., Cannons, A.C., Roberts, J., Haiduven, D., and Crowe, S. (2024). Detection of resistance to macrolides and fluoroquinolones in Mycoplasma genitalium by targeted next-generation sequencing. Microbiol. Spectr., 12.","DOI":"10.1128\/spectrum.03845-23"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Plummer, E.L., Murray, G.L., Bodiyabadu, K., Su, J., Garland, S.M., Bradshaw, C.S., Read, T., Tabrizi, S.N., and Danielewski, J. (2020). A custom amplicon sequencing approach to detect resistance associated mutations and sequence types in Mycoplasma genitalium. J. Microbiol. Methods, 179.","DOI":"10.1016\/j.mimet.2020.106089"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Abavisani, M., and Keikha, M. (2023). Global Analysis on the Mutations Associated with Multidrug-Resistant Urogenital Mycoplasmas and Ureaplasmas Infection: A Systematic Review and Meta-Analysis. Ann. Clin. Microbiol. Antimicrob., 22.","DOI":"10.1186\/s12941-023-00627-6"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Li, L., Yang, Y., He, W., Zheng, L., and Wang, Q. (2023). Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China. Diagn. Microbiol. Infect. Dis., 105.","DOI":"10.1016\/j.diagmicrobio.2022.115854"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/sextrans-2022-055678","article-title":"Multidrug-resistant Mycoplasma genitalium urethritis: Successful eradication with sequential therapy","volume":"99","author":"Raccagni","year":"2022","journal-title":"Sex. Transm. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: A prospective evaluation","volume":"68","author":"Read","year":"2018","journal-title":"Clin. Infect. Dis."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/4\/470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:25:04Z","timestamp":1760106304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/4\/470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["genes15040470"],"URL":"https:\/\/doi.org\/10.3390\/genes15040470","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}